Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Checkpoint Therapeutics, Inc.

TRADE

NASDAQ: CKPTHealthcare / Biotechnology / -
2.79-0.07-2.45%Vol 80 1701Y Perf -57.85%
Oct 17th, 2018 15:59
BID2.83 ASK2.96
Open2.87 Previous Close2.86
Pre-Market- After-Trading-
 - -%  - -%
Target Price
15.50 
Analyst Rating
Strong Buy 1.00
Potencial %
455.56 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)90 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
11.05 
Earnings Date
2nd Nov 2018

Today's Price Range

2.682.96

 

52wk Range

2.227.38

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
-34.20%
3 Months
8.14%
6 Months
-30.25%
1 Year
-57.85%
3 Years
-
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
CKPT2.79-0.0700-2.45
AAPL221.19-0.9600-0.43
GOOG1 115.69-5.5900-0.50
MSFT110.71-0.2900-0.26
XOM81.500.30000.37
WFC54.460.73001.36
JNJ139.462.90002.12
FB159.420.64000.40
GE12.190.09000.74
JPM109.831.21001.11
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 4.30
Current Ratio 4.40
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -
Leverage Ratio 1.30
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-2 367.70
EBITDA Margin-2 367.70
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 5.59
PS Ratios 119.70
Price to Cash Flow -
Price to Free Cash Flow -6.30
Cash Flow Per Share -0.79
Price to Tangible Book5.59
Book Value per Share0.69
Enterprise Value (in ths.)96 275
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-
ROE last 12 Months -115.62
Return on Assets (5Y Avg) -
ROA last 12 Months -94.13
Return on Capital (5Y Avg) -
ROC last 12 Months -116.04
Return on invested Capital Q -26.08
Return on invested Capital Y-96.21
Assets Turnover0.00
Receivables Turnover0.60
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)802
Revenue per Share 0.02
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018-0.35-0.2334.29
Q01 2018-0.19-0.35-84.21
Q04 2017-0.27-0.263.70
Q02 2017--0.28-
----
----
----
----
Earnings Per EndEstimateRevision %Trend
9/2018 QR-0.2235.29Positive
12/2018 QR-0.2233.33Positive
12/2018 FY-1.0225.00Positive
12/2019 FY-1.0821.17Positive
Next Report Date2nd Nov 2018
Estimated EPS Next Report-0.22
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume80 170
Shares Outstanding (in ths.)32 110
Trades Count279
Dollar Volume217 096
Avg. Volume94 917
Avg. Weekly Volume43 614
Avg. Monthly Volume218 258
Avg. Quarterly Volume159 690

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

73%27%

Bearish Bullish

59%41%

Bearish Bullish

33%67%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
2 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News

x